Until the three ongoing randomised controlled trials of preventive therapy are completed, there remains a large knowledge gap about how individuals known to have been exposed to multidrug-resistant TB (MDR-TB) should be managed. The evolving paradigms and improving outcomes from treatment of active MDR-TB disease play in to discussions about the relative merits and importance of intensive surveillance and/or preventive therapy for MDR-TB contacts. Keywords: MDR-TB, Multidrug resistant tuberculosis, Contact, Exposure, Preventive therap
BACKGROUND: Drug susceptibility testing (DST) patterns of Mycobacterium tuberculosis (MTB) from pati...
MDR-TB is a growing challenge worldwide, and an obstacle to TB elimination. It is apparent that TB i...
It is estimated that three of every 1,000 individuals worldwide have latent Multidrug-Resistant Tube...
Until the three ongoing randomised controlled trials of preventive therapy are completed, there rema...
The diagnosis of multidrug resistant tuberculosis (MDR-TB) in any individual is the beginning of a p...
The emergence of multidrug-resistant (MDR)-TB and, more recently, of extensively drug-resistant (XDR...
Adequate management of drug-resistant tuberculosis (TB), including multidrug- (MDR) and extensively ...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
Setting: The effectiveness of public health strategies following exposure to multidrug-resistant tub...
Multidrug-resistant tuberculosis (MDR-TB) is threatening control of TB in many parts of the world. A...
Summary: The global burden of tuberculosis (TB) is still large. The increasing incidence of drug-res...
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabili...
Despite enormous progress, tuberculosis (TB) is still a major global health problem. Poor patients’...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
Alberto Matteelli,1 Alberto Roggi,1 Anna CC Carvalho21Institute of Infectious and Tropical Diseases,...
BACKGROUND: Drug susceptibility testing (DST) patterns of Mycobacterium tuberculosis (MTB) from pati...
MDR-TB is a growing challenge worldwide, and an obstacle to TB elimination. It is apparent that TB i...
It is estimated that three of every 1,000 individuals worldwide have latent Multidrug-Resistant Tube...
Until the three ongoing randomised controlled trials of preventive therapy are completed, there rema...
The diagnosis of multidrug resistant tuberculosis (MDR-TB) in any individual is the beginning of a p...
The emergence of multidrug-resistant (MDR)-TB and, more recently, of extensively drug-resistant (XDR...
Adequate management of drug-resistant tuberculosis (TB), including multidrug- (MDR) and extensively ...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
Setting: The effectiveness of public health strategies following exposure to multidrug-resistant tub...
Multidrug-resistant tuberculosis (MDR-TB) is threatening control of TB in many parts of the world. A...
Summary: The global burden of tuberculosis (TB) is still large. The increasing incidence of drug-res...
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabili...
Despite enormous progress, tuberculosis (TB) is still a major global health problem. Poor patients’...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
Alberto Matteelli,1 Alberto Roggi,1 Anna CC Carvalho21Institute of Infectious and Tropical Diseases,...
BACKGROUND: Drug susceptibility testing (DST) patterns of Mycobacterium tuberculosis (MTB) from pati...
MDR-TB is a growing challenge worldwide, and an obstacle to TB elimination. It is apparent that TB i...
It is estimated that three of every 1,000 individuals worldwide have latent Multidrug-Resistant Tube...